Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9151
PUT
The Honest Company
HNST
$586M
| $36.8K | ﹤0.01% |
10,300
+300
| +3% | +$1.12K |
|
9152
FibroBiologics
FBLG
$6.5M
| $36.6K | ﹤0.01% |
+593
| New | +$39.4K |
|
|
TGB
9153
CALL
Trekor Metals
TGB
$3.05B
| $36.5K | ﹤0.01% |
14,500
-23,300
| -62% | -$51.8K |
|
|
CIF
9154
DELISTED
MFS Intermediate High Income Fund
CIF
| $36.5K | ﹤0.01% |
+20,490
| New | +$35.9K |
|
9155
CALL
Allogene Therapeutics
ALLO
$694M
| $36.4K | ﹤0.01% |
+13,000
| New | +$34.7K |
|
|
NCV
9156
Virtus Convertible & Income Fund
NCV
$390M
| $36.2K | ﹤0.01% |
+2,585
| New | +$35.2K |
|
9157
Purple Innovation
PRPL
$41.7M
| $35.6K | ﹤0.01% |
1,442
-1,638
| -53% | -$47.3K |
|
9158
CuriosityStream
CURI
$161M
| $35.6K | ﹤0.01% |
18,642
-27,297
| -59% | -$37.2K |
|
9159
Workhorse Group
WKHS
$36.3M
| $35.4K | ﹤0.01% |
272
+130
| +92% | +$22K |
|
|
CNL
9160
Collective Mining Ltd
CNL
$1.31B
| $35.2K | ﹤0.01% |
+10,983
| New | +$33.8K |
|
|
OPTU
9161
CALL
Optimum Communications Inc
OPTU
$301M
| $34.9K | ﹤0.01% |
14,200
-3,900
| -22% | -$7.53K |
|
|
HTZWW
9162
Hertz Global Holdings Warrants
HTZWW
$95.5M
| $34.4K | ﹤0.01% |
15,709
-4,509
| -22% | -$11K |
|
|
ALLK
9163
DELISTED
Allakos
ALLK
| $34.3K | ﹤0.01% |
52,495
-128,917
| -71% | -$93.3K |
|
9164
PUT
Globalstar
GSAT
$10.8B
| $34.2K | ﹤0.01% |
+1,840
| New | +$34K |
|
9165
Eve Holding
EVEX
$962M
| $34.1K | ﹤0.01% |
10,512
-19,349
| -65% | -$58.5K |
|
9166
LiveWire Group Warrants
LVWR.WS
$5.09M
| $34K | ﹤0.01% |
323,478
-7,221
| -2% | -$1.21K |
|
|
RPT
9167
Rithm Property Trust
RPT
$93.7M
| $33.6K | ﹤0.01% |
1,684
-4,462
| -73% | -$92.7K |
|
|
LSBPW
9168
DELISTED
LakeShore Biopharma Warrants
LSBPW
| $32.9K | ﹤0.01% |
498,301
| – | – |
|
9169
Upland Software
UPLD
$15.4M
| $32.9K | ﹤0.01% |
1,320
-421
| -24% | -$9.71K |
|
9170
Aterian
ATER
$5.37M
| $32.8K | ﹤0.01% |
+11,380
| New | +$34K |
|
|
RNWWW
9171
ReNew Energy Global PLC Warrant
RNWWW
$44.5K
| $32.5K | ﹤0.01% |
97,593
-7,156
| -7% | -$2.76K |
|
9172
Flux Power
FLUX
$11.4M
| $32.3K | ﹤0.01% |
+10,637
| New | +$35.8K |
|
9173
CALL
Leslie's
LESL
$11M
| $32.2K | ﹤0.01% |
510
-980
| -66% | -$60.4K |
|
9174
CytomX Therapeutics
CTMX
$754M
| $32.1K | ﹤0.01% |
27,231
-52,470
| -66% | -$66.6K |
|
9175
Werewolf Therapeutics
HOWL
$19.3M
| $32.1K | ﹤0.01% |
15,149
-13,431
| -47% | -$30.6K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.